Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00361166 | Antipsychotic and Motor Effects of ACP-103 When Administered in Combination With Haloperidol and Risperidone | PHASE2 | COMPLETED | 400 | — | — | Aug 1, 2005 | Mar 1, 2007 | Mar 22, 2007 | 17 | United States, Brazil |
| Name | Type | Description |
|---|---|---|
| ACP-103 | DRUG | - |
Inclusion Criteria: * male or female subjects ages 18-65 diagnosed with schizophrenia * experiencing an acute exacerbation of psychosis * has had prior response to antipsychotic therapy within the previous 3 years * female subjects must be of non-childbearing potential or must comply with double-ba...